Mabvinra Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Adalimumab (40mg/0.4ml)
Overview Mabvinra Injection
Infliximab injection, marketed as Mabvinra, addresses diverse inflammatory conditions including ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease. This medication alleviates associated inflammation, pain, and discomfort, enhancing overall mobility. Administration is strictly by a healthcare provider; self-injection is prohibited. Consistent daily dosing is crucial for optimal efficacy. Continue treatment as directed, completing the prescribed course even with symptom improvement. Potential side effects, such as headache, sinusitis, rash, upper respiratory infections, and localized injection site reactions (pain, redness, swelling), may occur. Persistent or worsening side effects warrant immediate medical consultation. Your physician can offer strategies for managing these. Prior to commencing treatment, disclose any pre-existing cardiac, renal, or hepatic conditions, and provide a comprehensive list of current medications. Pregnant or breastfeeding individuals should seek medical counsel before using Infliximab.
Primary Ingredients of Mabvinra Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Mabvinra Injection
Spondyloarthropathy | Inflammatory polyarthritis | Psoriatic arthritis | Inflammatory bowel disease (ulcerative colitis) | Inflammatory bowel disease (Crohn's disease)
Major Benefits of Mabvinra Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mabvinra Injection:
- Headache
- Sinus inflammation
- Rash
- Upper respiratory tract infection
- Injection site reaction
How to use Mabvinra Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Mabvinra Injection works:
Mabvinra Injection inhibits specific inflammatory mediators, thereby alleviating the swelling, redness, and inflammation characteristic of some arthritic conditions.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Mabvinra Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The use of Mabvinra Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Mabvinra Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Driving may be impaired by Mabvinra Injection side effects, such as dizziness and visual problems. These effects can compromise safe driving.
KidneyCONSULT YOUR DOCTOR
Data regarding Mabvinra Injection use in patients with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Mabvinra Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Mabvinra Injection :
Should you forget a Mabvinra Injection dose, seek your physician's advice.
Facts to Know About Mabvinra Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Biologic Disease-Modifying Antirheumatic Drugs (bDMARDs) |
3,018 People bought this recently